Alyeska Investment Group’s Ibere Pharmaceuticals IBER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-150,000
Closed -$1.47M 588
2022
Q2
$1.47M Hold
150,000
0.02% 438
2022
Q1
$1.47M Hold
150,000
0.02% 463
2021
Q4
$1.46M Hold
150,000
0.02% 486
2021
Q3
$1.45M Hold
150,000
0.02% 554
2021
Q2
$1.45M Buy
+150,000
New +$1.45M 0.02% 556